Shanghai Epidemiology Study for Adolescents and Children with Cancer
NCT02959086 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2025-02-13
Summary
The purpose of this study is to describe the morbidity, mortality, disability and survival rate in Shanghai adolescents and children with cancer diagnosed since January 2002.
Conditions
- Childhood Cancer
Sponsors & Collaborators
-
Shanghai Children's Medical Center
collaborator OTHER -
Shanghai Municipal Center for Disease Prevention & Control
collaborator UNKNOWN -
Children's Cancer Group, China
lead NETWORK
Principal Investigators
-
Yi-Jin Gao, MD · Shanghai Children's Medical Center
Eligibility
- Min Age
- 0 Years
- Max Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-01-31
- Primary Completion
- 2017-04-30
- Completion
- 2030-01-31
Countries
- China
Study Locations
More Related Trials
-
Effect of Target Therapy on Patients Undergoing Synchronic Hepatectomy for Colorectal Liver Metastases
NCT01677728 ·Status: UNKNOWN
-
Diagnosis, Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter, Two-way, Non-intervention Study
NCT04243057 ·Status: UNKNOWN
-
A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer
NCT02296658 ·Status: UNKNOWN ·Phase: PHASE2
-
Observational Study on the Patients With Rectal Cancer
NCT02312284 ·Status: COMPLETED
-
Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence
NCT06120127 ·Status: RECRUITING ·Phase: PHASE2
-
Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients
NCT02510118 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Discovery and Validate of Multi-genetic Biomarkers for Capecitabine in Chinese Colorectal Patients
NCT03030508 ·Status: UNKNOWN
-
The Value of ctDNA on Chemotherapy Efficacy for mCRC
NCT04555369 ·Status: UNKNOWN ·Phase: NA
-
Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)
NCT07283575 ·Status: RECRUITING
-
Dosimetric Limitation of Pelvic Bone and Peritoneal Space in Rectal Cancer Patients During Chemoradiotherapy
NCT05688033 ·Status: UNKNOWN ·Phase: NA
-
Camrelizumab Combined With Chemotherapy and Radiotherapy Perioperative Treatment of Esophageal Gastric Junction Adenocarcinoma
NCT06163729 ·Status: RECRUITING ·Phase: PHASE2
-
Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver Metastasis
NCT02453490 ·Status: TERMINATED ·Phase: PHASE3
-
Validate the Dosimetric Parameters That Correlate With Acute Hematologic Toxicity (HT) in Patients With Rectal Cancer
NCT02630056 ·Status: UNKNOWN
-
A Prospective Multicentre Clinical Study of Dynamic Monitoring of Plasma ctDNA Methylation Markers to Predict Recurrence of Colorectal Cancer After Complete Resection of Peritoneal Metastases
NCT06903325 ·Status: RECRUITING
-
Shenbai Granules for Preventing Recurrence of Low-Risk Colorectal Adenomas
NCT07123116 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis
NCT02912052 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect Study of Clinical Outcomes of Traditional Chinese Medicine to Advanced Gastric Cancer by Propensity Score
NCT02781285 ·Status: UNKNOWN
-
Survival Outcomes of Uterine Malignancies in Chinese Population
NCT03291275 ·Status: UNKNOWN
-
Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer
NCT02618356 ·Status: UNKNOWN ·Phase: PHASE2
-
Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Ⅲ Endometrial Cancer
NCT04453904 ·Status: RECRUITING ·Phase: NA
-
A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal Cancer
NCT04499586 ·Status: UNKNOWN ·Phase: PHASE2
-
Prospective, Observational, Real-world Oral Malignant Tumors Study
NCT02395367 ·Status: COMPLETED
-
Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT
NCT02638051 ·Status: COMPLETED ·Phase: PHASE2
-
Real World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in China
NCT04952103 ·Status: UNKNOWN
-
Clinical Analysis of HIPEC for T4 Colorectal Cancer After Surgery
NCT03221608 ·Status: UNKNOWN ·Phase: PHASE3